Creating new fluorescent dyes for imaging blood vessels
Official title: Developing Activatable Fluorescent Flavonoids for Vascular Imaging
Funded at University of Akron · NIH-11032470 · Data updated 2026-11-12
This study is working on creating special dyes that can light up certain parts of cells and blood vessels to help doctors see them better during imaging tests, which could improve how we diagnose eye conditions and other health issues.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Akron NIH-funded |
| Lab location | 1 site (Akron, United States) |
| Project start | March 1, 2023 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $90,049 |
| NIH project number | 3R15GM148965-01S1 |
| Project ID | NIH-11032470 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with vascular conditions or those requiring detailed imaging of blood vessels.
✕Less likely to help
Patients without vascular issues or those not requiring advanced imaging techniques may not benefit from this research.
What this research studies
This research focuses on developing advanced fluorescent molecular probes that can selectively highlight specific cellular structures and blood vessels for biomedical imaging. The team aims to acquire a modern fluorometer capable of detecting fluorescence in the near-infrared (NIR) region, which is essential for characterizing these new compounds. By improving the ability to analyze the fluorescent properties of these dyes, the project seeks to enhance imaging techniques that could lead to better diagnostic tools in ophthalmology and other fields.
Why it matters
Potential benefit: If successful, this research could lead to improved imaging techniques that enhance the diagnosis and treatment of vascular conditions.
How similar studies have gone: Other research has shown promise in using fluorescent probes for imaging, indicating that this approach has potential for success.
Where this research is happening
-
University of Akron
Akron, United States Active
Researchers
- Principal investigator: Pang, Yi — University of Akron
- Study coordinator: Pang, Yi
Related research
Other NIH-funded projects on the same topics.
-
CYP126A1 and CYP143A1: uncovering how these MTB enzymes work and can be blocked
Researchers are studying two Mycobacterium tuberculosis enzymes to understand how they work and how azole drugs might block them to help combat tuberculosis.
-
Imaging single photocatalytic turnovers to improve drug synthesis
A patient-friendly look at a project that aims to understand how light-powered catalysts work one molecule at a time to help make drugs more efficiently.
-
Improving engineered heart tissue for better cardiac models
This study is exploring new ways to grow heart cells in a lab that better mimic how they work in the real heart, which could help researchers understand heart diseases and test new treatments more effectively.
-
Creating special dyes for better imaging of blood vessels
This study is testing new glowing dyes that help scientists see blood vessels more clearly in living zebrafish, making it easier to understand how diseases affect them without any complicated steps.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.